ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992

Treanda Approved For B-Cell Non-Hodgkin’s Lymphoma

October 31, 2008

NIH To Replace RAC With New Committee

July 19, 1996

Cancer Incidence Rates Climb In HIV-Positive Female Populations

April 27, 2012

UC Davis Cancer Center Wins NCI Designation

July 19, 2002

In Brief: Two New Section Chiefs Named In NCI Research Contracts Branch; S. 988 Markup Set For April 25

April 18, 1980